Methylation-mediated silencing of miR-125a-5p facilitates breast cancer progression by inducing autophagy

被引：0
|
作者：
Fatemeh Ahmadpour
Somayeh Igder
Hossein Babaahmadi-Rezaei
Ehsan Khalili
Malek Kanani
Vahid Soleimani
Ghorban Mohammadzadeh
机构：
[1] Ahvaz Jundishapur University of Medical Sciences,Department of Clinical Biochemistry, School of Medicine, Cellular and Molecular Research Center, Medical Basic Science Research Institute
[2] Tehran University of Medical Sciences,Department of Clinical Biochemistry, School of Medicine
[3] Ahvaz Jundishapur University of Medical Sciences,Department of Pathology, Imam Khomeini Hospital
[4] Tehran University of Medical Sciences,Department of Pathology, Cancer Institute, Imam Khomeini Complex Hospital
[5] Ahvaz Jundishapur University of Medical Sciences,Department of Clinical Biochemistry, School of Medicine, Hyperlipidemia Research Center
来源：
Molecular Biology Reports | 2022年 / 49卷
关键词：
Breast cancer; Autophagy; Methylation; microRNA-125a;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6325 / 6339
页数：14
相关论文
共 50 条
  • [21] RNA methylation-mediated LINC01559 suppresses colorectal cancer progression by regulating the miR-106b-5p/PTEN axis
    Shi, Ke
    Yang, Shuaixi
    Chen, Chen
    Shao, Bo
    Guo, Yaxin
    Wu, Xiaoke
    Zhao, Luyang
    Yang, Xiuxiu
    Zhang, Qiuge
    Yuan, Weitang
    Sun, Zhenqiang
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (07): : 3048 - 3065
  • [22] Plasma exosomal miR-125a-5p and miR-141-5p as non-invasive biomarkers for prostate cancer
    Li, W.
    Dong, Y.
    Wang, K. J.
    Deng, Z.
    Zhang, W.
    Shen, H. F.
    NEOPLASMA, 2020, 67 (06) : 1314 - 1318
  • [23] Methylation-Mediated Silencing of RBP7 Promotes Breast Cancer Progression through PPAR and PI3K/AKT Pathway
    Lin, Hong
    Han, Qizheng
    Wang, Junhao
    Zhong, Zhaoqian
    Luo, Haihua
    Hao, Yibin
    Jiang, Yong
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [24] Low expression of miR-125a-5p is associated with poor prognosis in patients with gastric cancer
    Li, Guan
    Ao, Sheng
    Hou, Jianing
    Lyu, Guoqing
    ONCOLOGY LETTERS, 2019, 18 (02) : 1483 - 1490
  • [25] miR-125a-5p promotes gastric cancer growth and invasion by regulating the Hippo pathway
    Li, Ruixin
    Hu, Zhihao
    Wang, Zhuoyin
    Zhu, Tianyu
    Wang, Guojun
    Gao, Bulang
    Wang, Jingtao
    Deng, Xiumei
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (12)
  • [26] miR-125a-5p impairs the metastatic potential in breast cancer via IP6K1 targeting
    Minini, Mirko
    Senni, Alice
    He, Xingkang
    Proietti, Sara
    Liguoro, Domenico
    Catizone, Angela
    Giuliani, Alessandro
    Mancini, Rita
    Fuso, Andrea
    Cucina, Alessandra
    Cao, Yihai
    Bizzarri, Mariano
    CANCER LETTERS, 2021, 520 : 48 - 56
  • [27] Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer
    Watanabe, Kousuke
    Amano, Yosuke
    Ishikawa, Rie
    Sunohara, Mitsuhiro
    Kage, Hidenori
    Ichinose, Junji
    Sano, Atsushi
    Nakajima, Jun
    Fukayama, Masashi
    Yatomi, Yutaka
    Nagase, Takahide
    Ohishi, Nobuya
    Takai, Daiya
    CANCER MEDICINE, 2015, 4 (10): : 1573 - 1582
  • [28] miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis
    Hsieh, Tsung-Hua
    Hsu, Chia-Yi
    Tsai, Cheng-Fang
    Long, Cheng-Yu
    Chai, Chee-Yin
    Hou, Ming-Feng
    Lee, Jau-Nan
    Wu, Deng-Chyang
    Wang, Shao-Chun
    Tsai, Eing-Mei
    ONCOTARGET, 2015, 6 (01) : 494 - 509
  • [29] MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2
    Wang, Li-Bing
    Feng, Liang
    He, Jing
    Liu, Bo
    Sun, Jian-Guang
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2019, 16 (06) : 6923 - 6933
  • [30] Unlocking the Therapeutic Potential: Harnessing miR-125a-5p To Enhance Autophagy and Apoptosis in Pancreatic Cancer through Targeting STAT3
    Pan, Lujuan
    Qin, Zongshuai
    Zhou, Qinghong
    Zheng, Pin
    Li, Hua
    Zhou, Xihan
    Qin, Yueqiu
    JOURNAL OF CANCER, 2024, 15 (15): : 4955 - 4968
12345